Toward comprehensive value assessment for Alzheimer's disease innovations

Author:

Ferrell Phyllis B.1,Fillit Howard2,Neumann Peter J.3,Wall J. K.1,Murray James F.4

Affiliation:

1. Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana USA

2. Alzheimer's Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai New York New York USA

3. Center for the Evaluation of Value and Risk in Health Tufts Medical Center Boston Massachusetts USA

4. Davos Alzheimer's Collaborative Wayne Pennsylvania USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Reference66 articles.

1. A National Profile of Family and Unpaid Caregivers Who Assist Older Adults With Health Care Activities

2. Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States

3. The essential role of value assessment in addressing the global dementia crisis in Valuing future Alzheimer's disease treatments: the need for a holistic approach;Barbarino P;Value Outcomes Spotlight,2021

4. Long‐term value demonstration in Alzheimer's disease: evidence needs in Valuing future Alzheimer's disease treatments: the need for a holistic approach;Barbarino P;Value Outcomes Spotlight,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3